Sorry, you need to enable JavaScript to visit this website.
An official website of the European UnionAn official EU website
English (en)

Integrated reducer-filter-injector unit for natural gas engines


Integrated reducer-filter-injector unit for natural gas engines

Link to CORDIS:

Converting conventionally fuelled vehicles to run on cheaper and more sustainable fuel alternatives like Liquefied Petroleum Gas (LPG) and Compressed Natural Gas (CNG) has become increasingly important as society is moving towards creating cities with minimum emissions. This requires modifying the fuel injection system to use the alternative fuels via a conversion kit. As Rail, we envisaged a novel approach to conversion kits manufacture and have developed as well as patented an innovation that will transform the performance of conversion kits. Our solution, InjectoReducer, provides an enabling technology towards meeting the rule requirement for Euro 4-6 Regulation Compliance. It offers reduced (handling, installation and maintenance) costs, increased energy efficiency, reduced emissions, increased ease and speed of installation as well as servicing.

As such, InjectoReducer has been developed in line with Europe's transport and mobility goals for the year 2050. Our solution will be an enabling innovation towards ridding cities of conventionally-fuelled cars in cities as well as reducing 60% of transport emissions by the middle of the century. InjectoReducer will be relevant to the Autogas equipment kit Original Equipment Manufacturers (OEMs) and the Aftermarket fitment market for 1-2 cylinder and 3-4 cylinder vehicles. The market is estimated to grow from 15million to 25milllon units with an attached forecast value from €6.27B to €10.75B by 2021.


In our Phase 1, we will conduct a feasibility study that will position us to develop a comprehensive business plan for InjectoReducer. This plan will provide the layout and procedure we will employ so as to fully exploit the conversion kit market for both the OEMs and the Aftermarket fitment market segments.

We will develop a market-ready product prototype in our Phase 2 in anticipation of the InjectoReducer commercial version release.

Institution Type:
Institution Name: 
European Commission
Type of funding:
Lead Organisation: 

Rail Srl

EU Contribution: 
Development phase: